Trials
Search / Trial NCT05644990

T2MR PCR Detection of ESKAPE Pathogens in Patients With Pyogenic Spondylodiscitis and Infective Endocarditis

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Dec 8, 2022

Trial Information

Current as of January 21, 2025

Recruiting

Keywords

Spondylodiscitis Endocarditis Pcr T2 Bacteria Panel Mri

ClinConnect Summary

This clinical trial is investigating a new way to quickly identify specific bacteria that cause serious infections in the spine and heart, known as pyogenic spondylodiscitis and infective endocarditis. The study uses a special test called the T2 Bacteria Panel, which looks for bacterial DNA in blood samples. It aims to find these infections faster and more accurately than traditional methods, which could help doctors start the right treatment sooner, improve patient outcomes, and reduce the risk of antibiotic resistance.

To participate in this trial, individuals must be diagnosed with either spondylodiscitis or infective endocarditis and should not have received antibiotics for more than 24 hours. Participants will have their blood tested using the new method, and their results will help researchers understand how well this test works compared to standard procedures. This study is currently recruiting participants of all genders, aged 65 and older, who can provide informed consent.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of spondylodiscitis or/and facet joint infection or/and sacroileitis
  • Diagnosis of infective endocarditis
  • Antibiotic treatment not received or not longer than 24 hours
  • Ability to give informed consent
  • Exclusion Criteria:
  • Spine infection or/and endocarditis not confirmed
  • Antibiotic treatment longer than 24 hours
  • Inability to give informed consent

About Charles University, Czech Republic

Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.

Locations

Prague, , Czechia

Prague, , Czechia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials